Literature DB >> 21850059

Blood pressure, thyroid-stimulating hormone, and thyroid disease prevalence in primary aldosteronism and essential hypertension.

Federica Turchi1, Vanessa Ronconi, Valentina di Tizio, Marco Boscaro, Gilberta Giacchetti.   

Abstract

BACKGROUND: A positive correlation between thyroid-stimulating hormone (TSH) and blood pressure (BP) has been identified in normotensives and in patients with essential hypertension (EH). This study was designed to evaluate, in primary aldosteronism (PA) and in EH, potential association of BP, TSH, and ultrasonographic changes of the thyroid.
METHODS: We studied 188 patients: 92 with PA and 96 matched essential hypertensives. Clinical and ambulatory BP (ABP), and thyroid function were evaluated in all patients. In PA and in a subgroup of EH patients (n = 65) thyroid ultrasonography was performed.
RESULTS: In PA patients, diastolic office and diastolic ABP increased across TSH quartiles and multivariate analysis confirmed a positive significant correlation between TSH and diastolic BP, independently of aldosterone levels, body mass index (BMI), duration of hypertension, and age. In EH patients, we found a significant linear increase in systolic and diastolic ABP with increasing TSH. The prevalence of thyroid dysfunctions was similar in PA and EH (15% and 19%, respectively). In PA patients, we found a higher prevalence of ultrasonographic alterations than in EH (66% vs. 46%, P < 0.05). PA patients presenting morphological abnormalities had higher homeostasis model assessment-insulin resistance levels than patients with normal gland at ultrasonography (4.2 ± 1.8 vs. 3.1 ± 0.8 P < 0.05).
CONCLUSIONS: We found a positive correlation between TSH and BP both in PA and EH patients. Moreover, in PA patients we observed a high prevalence of thyroid morphological alterations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21850059     DOI: 10.1038/ajh.2011.144

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  6 in total

1.  Association of primary aldosteronism with chronic thyroiditis.

Authors:  Chiara Sabbadin; Caterina Mian; Davide Nacamulli; Gabriella Donà; Fabio Presotto; Corrado Betterle; Marco Boscaro; Luciana Bordin; Decio Armanini
Journal:  Endocrine       Date:  2016-02-09       Impact factor: 3.633

2.  Mining Chemical Activity Status from High-Throughput Screening Assays.

Authors:  Othman Soufan; Wail Ba-alawi; Moataz Afeef; Magbubah Essack; Valentin Rodionov; Panos Kalnis; Vladimir B Bajic
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

3.  Coexistence of Primary Hyperaldosteronism and Graves' Disease, a Rare Combination of Endocrine Disorders: Is It beyond a Coincidence-A Case Report and Review of the Literature.

Authors:  S S C Gunatilake; U Bulugahapitiya
Journal:  Case Rep Endocrinol       Date:  2017-10-30

4.  Prevalence of hypothyroidism in patients with type 2 diabetes mellitus and hypertension in India: a cross-sectional observational study.

Authors:  Pradeep Talwalkar; Vaishali Deshmukh; Milind Bhole
Journal:  Diabetes Metab Syndr Obes       Date:  2019-03-20       Impact factor: 3.168

5.  The Impact of Glucocorticoid Co-Secretion in Primary Aldosteronism on Thyroid Autoantibody Titers During the Course of Disease.

Authors:  Laura Handgriff; Christian Adolf; Daniel A Heinrich; Leah Braun; Nina Nirschl; Lisa Sturm; Roland Ladurner; Jens Ricke; Max Seidensticker; Martin Bidlingmaier; Martin Reincke
Journal:  Horm Metab Res       Date:  2020-05-13       Impact factor: 2.936

6.  Association of Papillary Thyroid Carcinoma with Primary Aldosteronism.

Authors:  Shigenori Nakamura; Masatoshi Ishimori; Noriyoshi Yamakita
Journal:  Intern Med       Date:  2018-10-17       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.